These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34098740)

  • 1. Sex-Based Differences in Bleeding Risk After Percutaneous Coronary Intervention and Implications for the Academic Research Consortium High Bleeding Risk Criteria.
    Spirito A; Gragnano F; Corpataux N; Vaisnora L; Galea R; Svab S; Gargiulo G; Siontis GCM; Praz F; Lanz J; Billinger M; Hunziker L; Stortecky S; Pilgrim T; Capodanno D; Urban P; Pocock S; Mehran R; Heg D; Windecker S; Räber L; Valgimigli M
    J Am Heart Assoc; 2021 Jun; 10(12):e021965. PubMed ID: 34098740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient-Level Pooled Analysis From 4 Postapproval Studies.
    Chandiramani R; Cao D; Claessen BE; Sorrentino S; Guedeney P; Blum M; Goel R; Roumeliotis A; Krucoff M; Kozuma K; Ge J; Seth A; Makkar R; Bangalore S; Bhatt DL; Angiolillo DJ; Ruster K; Wang J; Saito S; Neumann FJ; Hermiller J; Valgimigli M; Mehran R
    J Am Heart Assoc; 2020 Apr; 9(7):e014611. PubMed ID: 32223396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.
    Natsuaki M; Morimoto T; Shiomi H; Yamaji K; Watanabe H; Shizuta S; Kato T; Ando K; Nakagawa Y; Furukawa Y; Tada T; Nagao K; Kadota K; Toyofuku M; Kimura T
    Circ Cardiovasc Interv; 2019 Nov; 12(11):e008307. PubMed ID: 31707804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores.
    Ueki Y; Bär S; Losdat S; Otsuka T; Zanchin C; Zanchin T; Gragnano F; Gargiulo G; Siontis GCM; Praz F; Lanz J; Hunziker L; Stortecky S; Pilgrim T; Heg D; Valgimigli M; Windecker S; Räber L
    EuroIntervention; 2020 Aug; 16(5):371-379. PubMed ID: 32065586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome.
    Shimono H; Tokushige A; Kanda D; Ohno A; Hayashi M; Fukuyado M; Akao M; Kawasoe M; Arikawa R; Otsuji H; Chaen H; Okui H; Oketani N; Ohishi M
    J Cardiol; 2023 Jun; 81(6):553-563. PubMed ID: 36682715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the academic research consortium high bleeding risk definition in Thai PCI registry.
    Roongsangmanoon W; Wongsoasup A; Chichareon P; Suwannasom P; Chandavimol M; Limpijankit T; Srimahachota S; Hutayanon P; Kiatchoosakun S; Siriwiwattnakul N; Promlikitchai P; Siriyotha S; Thakkinstian A; Sansanayudh N
    Int J Cardiol; 2023 Oct; 388():131167. PubMed ID: 37429447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Academic Research Consortium for High Bleeding Risk criteria in Chinese patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention.
    Lyu SQ; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Yang YM
    Thromb Res; 2022 Jan; 209():16-22. PubMed ID: 34844044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients.
    Cao D; Mehran R; Dangas G; Baber U; Sartori S; Chandiramani R; Stefanini GG; Angiolillo DJ; Capodanno D; Urban P; Morice MC; Krucoff M; Goel R; Roumeliotis A; Sweeny J; Sharma SK; Kini A
    J Am Coll Cardiol; 2020 Jun; 75(21):2711-2722. PubMed ID: 32466887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition.
    Gragnano F; Spirito A; Corpataux N; Vaisnora L; Galea R; Gargiulo G; Siontis GCM; Praz F; Lanz J; Billinger M; Hunziker L; Stortecky S; Pilgrim T; Bär S; Ueki Y; Capodanno D; Urban P; Pocock SJ; Mehran R; Heg D; Windecker S; Räber L; Valgimigli M
    EuroIntervention; 2021 Dec; 17(11):e898-e909. PubMed ID: 34105513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRECISE-DAPT, ARC-HBR, or Simplified Clinical Evaluation for the Prediction of Major Bleeding After Percutaneous Coronary Intervention in older Patients.
    Marschall AF; Duarte Torres J; Biscotti Rodíl B; Gómez Sánchez I; Basabe Velasco E; Ramos Alejos-Pita C; López Soberón E; Suárez Cuervo A; Álvarez Antón S; de la Torre Hernández JM; Martí Sánchez D
    Am J Cardiol; 2024 May; 219():103-109. PubMed ID: 38552712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Ability of Academic Research Consortium for High Bleeding Risk Criteria in ST-Elevation Myocardial Infarction Patients Undergoing Primary Coronary Intervention.
    Fujii T; Ikari Y
    Circ J; 2021 Jan; 85(2):159-165. PubMed ID: 33177266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transradial vs. Transfemoral Percutaneous Coronary Intervention in Patients With or Without High Bleeding Risk Criteria.
    Yamamoto K; Natsuaki M; Morimoto T; Shiomi H; Watanabe H; Yamaji K; Watanabe H; Kato T; Saito N; Ando K; Kadota K; Furukawa Y; Kimura T;
    Circ J; 2020 Apr; 84(5):723-732. PubMed ID: 32188831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applicability of the Academic Research Consortium for High Bleeding Risk in acute coronary syndrome undergoing percutaneous coronary intervention.
    Abu-Assi E; Raposeiras-Roubín S; Cespón Fernández M; Caneiro Queija B; Melendo Viu M; Íñiguez Romo A
    Rev Esp Cardiol (Engl Ed); 2022 May; 75(5):375-383. PubMed ID: 33865751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Academic Research Consortium High Bleeding Risk (ARC-HBR) criteria in patients undergoing peripheral endovascular interventions.
    Tomoi Y; Kuramitsu S; Shinozaki T; Soga Y; Kodama K; Imada K; Hiramori S; Ando K
    EuroIntervention; 2023 Apr; 18(16):e1368-e1377. PubMed ID: 36579610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of the Academic Research Consortium high bleeding risk criteria in patients undergoing endovascular therapy for peripheral artery disease in lower extremities.
    Hashimoto R; Numasawa Y; Yokokura S; Daigo K; Sakata S; Imaeda S; Hitomi Y; Sato K; Taruoka A; Haginiwa S; Kojima H; Tanaka M; Kuno T; Kodaira M
    Heart Vessels; 2021 Sep; 36(9):1350-1358. PubMed ID: 33651134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison and Validation of Long-Term Bleeding Events for Academic Bleeding Risk (ARC-HBR) Criteria and Contemporary Risk Scores for Percutaneous Coronary Intervention With a Second-Generation Drug Eluting Stent.
    Okabe K; Miura K; Shima Y; Ikuta A; Taguchi Y; Takahashi K; Osakada K; Ohya M; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
    Circ J; 2022 Aug; 86(9):1379-1387. PubMed ID: 35400715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the academic research consortium high bleeding risk criteria in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of 10 studies and 67,862 patients.
    Silverio A; Di Maio M; Buccheri S; De Luca G; Esposito L; Sarno G; Vecchione C; Galasso G
    Int J Cardiol; 2022 Jan; 347():8-15. PubMed ID: 34774882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
    Sorrentino S; Claessen BE; Chandiramani R; Guedeney P; Vogel B; Baber U; Rau V; Wang J; Krucoff M; Kozuma K; Ge J; Seth A; Makkar R; Liu Y; Bangalore S; Bhatt DL; Angiolillo DJ; Saito S; Neumann FJ; Hermiller J; Valgimigli M; Mehran R
    Circulation; 2020 Mar; 141(11):891-901. PubMed ID: 31992063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Comers Registry of Percutaneous Coronary Intervention　- From the CREDO-Kyoto Registry Cohort-3.
    Natsuaki M; Morimoto T; Shiomi H; Ehara N; Taniguchi R; Tamura T; Tada T; Suwa S; Kaneda K; Watanabe H; Tazaki J; Watanabe S; Yamamoto E; Saito N; Fuki M; Takeda T; Eizawa H; Shinoda E; Mabuchi H; Shirotani M; Uegaito T; Matsuda M; Takahashi M; Inoko M; Tamura T; Ishii K; Onodera T; Sakamoto H; Aoyama T; Sato Y; Ando K; Furukawa Y; Nakagawa Y; Kadota K; Kimura T;
    Circ J; 2021 May; 85(6):769-781. PubMed ID: 33298644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of original and modified Academic Research Consortium for High Bleeding Risk definitions in real-world practice.
    Takahashi K; Miura K; Shima Y; Okabe K; Ikuta A; Taguchi Y; Ohya M; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
    J Cardiol; 2022 Aug; 80(2):155-161. PubMed ID: 35282943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.